Læs hele meddelelsen
Ledelsens handel med Novozymes A/S B-aktier
I henhold til Værdipapirhandelslovens § 28a skal Novozymes offentliggøre følgende transaktioner under Fondskode DK0010272129, Novozymes B-aktier under betegnelsen NZYM B.
| Source: Novonesis (Novozymes A/S)
Recommended Reading
-
COPENHAGEN, Denmark – May 5, 2026. In the first quarter of 2026, Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.8%. Ester Baiget, President & CEO: ...
Read More -
Strong start to the year with 7% organic sales growth and 37.8% adjusted EBITDA margin Ester Baiget, President & CEO:” The year started strong with 7% organic sales growth against a high...
Read More